Published in Int J Obes (Lond) on December 22, 2009
The Effect of Allopurinol on Insulin Resistance and Blood Pressure | NCT00639756
Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care (2010) 8.52
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol (2010) 2.50
The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol (2014) 2.13
Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes (2013) 2.03
Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. J Pediatr Gastroenterol Nutr (2012) 1.82
Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proc Natl Acad Sci U S A (2012) 1.72
Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology (2012) 1.57
Serum uric acid and hypertension in adults: a paradoxical relationship in type 1 diabetes. J Clin Hypertens (Greenwich) (2014) 1.41
Dietary fructose causes tubulointerstitial injury in the normal rat kidney. Am J Physiol Renal Physiol (2010) 1.34
Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans. Nutr Metab (Lond) (2012) 1.33
The effects of fructose intake on serum uric acid vary among controlled dietary trials. J Nutr (2012) 1.32
Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake. Metabolism (2011) 1.27
Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep (2013) 1.20
Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects. Metabolism (2011) 1.15
Could the Sasang constitution itself be a risk factor of abdominal obesity? BMC Complement Altern Med (2013) 1.13
Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am J Clin Nutr (2014) 1.05
Misconceptions about fructose-containing sugars and their role in the obesity epidemic. Nutr Res Rev (2014) 1.02
Honey--a novel antidiabetic agent. Int J Biol Sci (2012) 1.01
The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease. Open Heart (2014) 1.01
No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach. Diabetologia (2011) 0.99
Fructose and uric acid in diabetic nephropathy. Diabetologia (2015) 0.99
Obesity in CKD--what should nephrologists know? J Am Soc Nephrol (2013) 0.98
Fructose: a key factor in the development of metabolic syndrome and hypertension. J Nutr Metab (2013) 0.97
Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans. Am J Physiol Gastrointest Liver Physiol (2014) 0.97
Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet. Hypertension (2014) 0.95
Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med (2013) 0.95
Health effects of fructose and fructose-containing caloric sweeteners: where do we stand 10 years after the initial whistle blowings? Curr Diab Rep (2015) 0.95
Fructose toxicity: is the science ready for public health actions? Curr Opin Clin Nutr Metab Care (2012) 0.91
Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease. Nephrol Dial Transplant (2011) 0.90
Early life exposure to fructose and offspring phenotype: implications for long term metabolic homeostasis. J Obes (2014) 0.88
Uric acid in metabolic syndrome: From an innocent bystander to a central player. Eur J Intern Med (2015) 0.87
World congress on insulin resistance, diabetes, and cardiovascular disease: Part 1. Diabetes Care (2011) 0.85
High dietary fructose intake: Sweet or bitter life? World J Diabetes (2011) 0.83
Increased methylglyoxal formation with upregulation of renin angiotensin system in fructose fed Sprague Dawley rats. PLoS One (2013) 0.83
Usefulness of combining serum uric acid and high-sensitivity C-reactive protein for risk stratification of patients with metabolic syndrome in community-dwelling women. Endocrine (2013) 0.83
The mechanisms underlying fructose-induced hypertension: a review. J Hypertens (2015) 0.81
Fructose Metabolism and Relation to Atherosclerosis, Type 2 Diabetes, and Obesity. J Nutr Metab (2015) 0.81
Dietary fructose-related adiposity and glucocorticoid receptor function in visceral adipose tissue of female rats. Eur J Nutr (2014) 0.79
The impact of fructose on renal function and blood pressure. Int J Nephrol (2011) 0.79
Total fructose intake and risk of hypertension: a systematic review and meta-analysis of prospective cohorts. J Am Coll Nutr (2014) 0.79
Pathogenesis of Cardiovascular and Metabolic Diseases: Are Fructose-Containing Sugars More Involved Than Other Dietary Calories? Curr Hypertens Rep (2016) 0.78
Dietary approach in the treatment of nonalcoholic fatty liver disease. World J Hepatol (2015) 0.78
Direct renal effects of a fructose-enriched diet: interaction with high salt intake. Am J Physiol Regul Integr Comp Physiol (2015) 0.77
Fructokinase, Fructans, Intestinal Permeability, and Metabolic Syndrome: An Equine Connection? J Equine Vet Sci (2013) 0.77
Fructose consumption reduces hippocampal synaptic plasticity underlying cognitive performance. Biochim Biophys Acta (2015) 0.76
Maternal Fructose Intake Affects Transcriptome Changes and Programmed Hypertension in Offspring in Later Life. Nutrients (2016) 0.76
The Effects of Lowering Uric Acid Levels Using Allopurinol on Components of Metabolic Syndrome. Cardiol Res (2012) 0.75
Lower Doses of Fructose Extend Lifespan in Caenorhabditis elegans. J Diet Suppl (2016) 0.75
Mitochondrial Medicine Arrives to Prime Time in Clinical Care: Nutritional Biochemistry and Mitochondrial Hyperpermeability ("Leaky Mitochondria") Meet Disease Pathogenesis and Clinical Interventions. Integr Med (Encinitas) (2014) 0.75
Fructose as cause of metabolic syndrome is poorly supported. Int J Obes (Lond) (2010) 0.75
Cardiovascular effects of high-fructose intake in rats with nitric oxide deficiency. Interdiscip Toxicol (2014) 0.75
Added sugars drive nutrient and energy deficit in obesity: a new paradigm. Open Heart (2016) 0.75
Opposing effects of sodium intake on uric acid and blood pressure and their causal implication. J Am Soc Hypertens (2016) 0.75
ILSI Brazil International Workshop on Functional Foods: a narrative review of the scientific evidence in the area of carbohydrates, microbiome, and health. Food Nutr Res (2013) 0.75
Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis. Mediators Inflamm (2016) 0.75
Perspective: A Historical and Scientific Perspective of Sugar and Its Relation with Obesity and Diabetes. Adv Nutr (2017) 0.75
Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm (1978) 10.01
mRNA polyadenylate-binding protein: gene isolation and sequencing and identification of a ribonucleoprotein consensus sequence. Mol Cell Biol (1986) 7.07
On the coronary circulation in the heart-lung preparation. J Physiol (1922) 5.97
Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene (2010) 4.81
A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn (1981) 4.73
Noncontact anterior cruciate ligament injuries: risk factors and prevention strategies. J Am Acad Orthop Surg (2000) 4.61
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science (2000) 4.14
Predictive factors of response to intravenous ciclosporin in severe ulcerative colitis: the development of a novel prediction formula. Aliment Pharmacol Ther (2012) 3.91
Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell (2001) 3.49
Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm (1978) 3.27
IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science (1993) 3.13
Intestinal lymphangiectasia markedly improved with antiplasmin therapy. Gastroenterology (1989) 2.88
Dynamics of centromeres during metaphase-anaphase transition in fission yeast: Dis1 is implicated in force balance in metaphase bipolar spindle. Mol Biol Cell (1998) 2.79
Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun (1994) 2.73
Local hyperthermia in combination with definitive radiotherapy: increased tumor clearance, reduced recurrence rate in extended follow-up. Int J Radiat Oncol Biol Phys (1984) 2.72
Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature (1996) 2.70
Amantadine and pneumonia. Lancet (1999) 2.69
In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci. Antimicrob Agents Chemother (1996) 2.63
Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum (2000) 2.61
Factors effecting late results after meniscectomy. J Bone Joint Surg Am (1974) 2.49
Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int (2006) 2.44
ACE inhibitors and pneumonia. Lancet (1998) 2.38
Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer (1994) 2.34
Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors. J Immunol (1982) 2.26
Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology (1999) 2.19
The use of health services by older adults. J Gerontol (1991) 2.18
Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J Cell Biol (2000) 2.14
Prospective study of follow up alone in stage I teratoma of the testis. Br Med J (Clin Res Ed) (1983) 2.13
p300-mediated acetylation facilitates the transfer of histone H2A-H2B dimers from nucleosomes to a histone chaperone. Genes Dev (2000) 2.03
Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int (1992) 2.02
Mechanical changes in the knee after meniscectomy. J Bone Joint Surg Am (1976) 2.00
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol (2001) 1.98
Characterization of a fission yeast SUMO-1 homologue, pmt3p, required for multiple nuclear events, including the control of telomere length and chromosome segregation. Mol Cell Biol (1999) 1.97
Strain within the anterior cruciate ligament during hamstring and quadriceps activity. Am J Sports Med (1986) 1.95
The mesenchymal factor, FGF10, initiates and maintains the outgrowth of the chick limb bud through interaction with FGF8, an apical ectodermal factor. Development (1997) 1.92
FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trial. J Dent Res (2010) 1.92
Effect of recombinant IL 2 and gamma-IFN on proliferation and differentiation of human B cells. J Immunol (1985) 1.92
Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest (1994) 1.91
Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol (2001) 1.90
Trends in skiing injuries. Analysis of a 6-year study (1972 to 1978). Am J Sports Med (1980) 1.86
The risk of nursing home placement and subsequent death among older adults. J Gerontol (1992) 1.86
Structure and expression of mouse furin, a yeast Kex2-related protease. Lack of processing of coexpressed prorenin in GH4C1 cells. J Biol Chem (1990) 1.85
Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol (1998) 1.83
A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J Immunol (1997) 1.83
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest (1994) 1.83
Localization of furin to the trans-Golgi network and recycling from the cell surface involves Ser and Tyr residues within the cytoplasmic domain. J Biol Chem (1995) 1.80
Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest (1995) 1.77
Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem (1994) 1.76
New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest (1987) 1.75
A "weight-listing" paradox for candidates of renal transplantation? Am J Transplant (2006) 1.75
Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int (2001) 1.75
The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol (1988) 1.73
Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int (2000) 1.72
Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am J Pathol (2000) 1.71
Prevalence of mitochondrial gene mutations among hearing impaired patients. J Med Genet (2000) 1.71
Changes in functional status and the risks of subsequent nursing home placement and death. J Gerontol (1993) 1.71
Molecular cloning and cDNA sequencing of endoxyloglucan transferase, a novel class of glycosyltransferase that mediates molecular grafting between matrix polysaccharides in plant cell walls. J Biol Chem (1993) 1.70
Percutaneous microwave coagulation therapy for solitary metastatic liver tumors from colorectal cancer: a pilot clinical study. Am J Gastroenterol (1999) 1.69
The Xenopus IP3 receptor: structure, function, and localization in oocytes and eggs. Cell (1993) 1.68
The strain behavior of the anterior cruciate ligament during squatting and active flexion-extension. A comparison of an open and a closed kinetic chain exercise. Am J Sports Med (1998) 1.68
Perceived health status and mortality among older men and women. J Gerontol (1992) 1.67
Gastrostomy insertion: comparing the options--PEG, RIG or PIG? Clin Radiol (2003) 1.67
Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. Kidney Int (2007) 1.66
Heat shock proteins and thermotolerance; a comparison of induction kinetics. Br J Radiol (1982) 1.64
Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest (1993) 1.63
Anterior cruciate ligament strain behavior during rehabilitation exercises in vivo. Am J Sports Med (1995) 1.63
Persistent Campylobacter jejuni infection in an immunocompromised patient. Ann Intern Med (1984) 1.62
Cut1 is loaded onto the spindle by binding to Cut2 and promotes anaphase spindle movement upon Cut2 proteolysis. Curr Biol (1998) 1.62
Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int (1991) 1.61
Horner syndrome occurring as a complication of chest tube placement. Radiology (1987) 1.60
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60
Identification of the fourth member of the mammalian endoprotease family homologous to the yeast Kex2 protease. Its testis-specific expression. J Biol Chem (1992) 1.58
A method to help reduce the risk of serious knee sprains incurred in alpine skiing. Am J Sports Med (1996) 1.58
B cell growth and differentiation factors and mechanism of B cell activation. Immunol Rev (1984) 1.57
Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells. J Immunol (1983) 1.57
Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer (1999) 1.56
Structure-function relationships of the mouse inositol 1,4,5-trisphosphate receptor. Proc Natl Acad Sci U S A (1991) 1.55
Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in chorea-acanthocytosis: a combined PET and MRI study. Mov Disord (1998) 1.54
Urinary tract obstruction and nephrostomy drainage in pelvic malignant disease. Br J Urol (1995) 1.54
Herpes simplex virus myelitis: clinical manifestations and diagnosis by the polymerase chain reaction method. Eur Neurol (1998) 1.53
The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion. Eye (Lond) (2003) 1.53
Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis (2001) 1.52
Hepatic infarction following percutaneous ethanol injection therapy for hepatocellular carcinoma. Eur J Gastroenterol Hepatol (1998) 1.51
An electrogoniometric study of knee motion in normal gait. J Bone Joint Surg Am (1970) 1.51
The biomechanics of anterior cruciate ligament rehabilitation and reconstruction. Am J Sports Med (1984) 1.50
The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia (2011) 1.50
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int (2001) 1.50
The effect of weightbearing and external loading on anterior cruciate ligament strain. J Biomech (2001) 1.50
In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses. Eur J Immunol (2001) 1.48
Serotonin suppresses N-methyl-D-aspartate responses in acutely isolated spinal dorsal horn neurons of the rat. Brain Res (1990) 1.47
Biocompatibility of hemodialysis membranes: evaluation in an ovine model. J Lab Clin Med (1993) 1.46
Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int (1992) 1.46
Identification of an endotoxin and IFN-inducible cDNA: possible identification of a novel protein family. J Leukoc Biol (1995) 1.45
Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. Br J Haematol (1997) 1.45
Downhill skiing injuries in children. Am J Sports Med (1984) 1.45
Overuse injuries in sports. A review. Sports Med (1985) 1.44
Intracranial vascular stenosis and occlusion: diagnostic accuracy of three-dimensional, Fourier transform, time-of-flight MR angiography. Radiology (1994) 1.44